ANO1 inhibits ferroptosis in tumor cells via phosphatidylinositol‐3‐kinase (PI3K)–Akt signaling and activates CAFs through TGF‐β release, while suppressing CD8+ T cell cytotoxicity, thereby exacerbating tumor progression. The gene discussed is TGFB1; the disease is neoplasm.